With decades of expertise in health science regulatory affairs, technology, and commercialisation,
Denis Japan provides cutting-edge technology
developers a base from which to market the following
in Japan: in-vitro diagnostics reagents, nuclear
medicine and sterilisation devices, A.I. & cloud-based
medical solutions, functional & active ingredients for
food, cosmetic and pharmaceutical industries.
Entry point to
Japan and ASEAN
for cutting-edge
health science
solutions.
With decades of expertise in health science regulatory affairs, technology, and commercialisation, Denis Japan provides cutting-edge technology developers a base from which to market the following in Japan: in-vitro diagnostics reagents, nuclear medicine and sterilisation devices, A.I. & cloud-based medical solutions, functional & active ingredients for food, cosmetic and pharmaceutical industries.
Entry point to Japan and ASEAN for cutting-edge health science solutions.
Diagnostic Reagent Business
Denis Pharma K.K imports, manufactures, and distributes innovative solutions in Japan and abroad in the segments of in-vitro diagnostics and research reagents. The company has become a major domestic player in the fields of RIA in-vitro diagnostics and pharmaceutical drug screening solutions in Japan.
Diagnostic Reagent Business
Denis Pharma K.K imports, manufactures, and distributes innovative solutions in Japan and abroad in the segments of in-vitro diagnostics and research reagents. The company has become a major domestic player in the fields of RIA in-vitro diagnostics and pharmaceutical drug screening solutions in Japan.
Nuclear Medicine And Sterilization Devices
Denis Japan, under its company Sceti K.K. implements and services foreign technologies in Japan in nuclear medical devices solutions for radio-pharmaceuticals manufacturing (PET/SPECT), medical imaging devices, radio-therapy equipment & accessories. Sceti K.K. also offers specific expertise in nuclear technology sterilization devices.
Nuclear Medicine And Sterilization Devices
Denis Japan, under its company Sceti K.K. implements and services foreign technologies in Japan in nuclear medical devices solutions for radio-pharmaceuticals manufacturing (PET/SPECT), medical imaging devices, radio-therapy equipment & accessories. Sceti K.K. also offers specific expertise in nuclear technology sterilization devices.
A.I. & Cloud Based Medical Solutions
Sceti K.K. also helps foreign technologies enter the Japanese market in the cutting-edge field of artificial intelligence medical solutions with two objectives: devices to improve patient comfort and medical imaging AI software to speed up complex reading analysis by radiologists.
A.I. & Cloud Based Medical Solutions
Sceti K.K. also helps foreign technologies enter the Japanese market in the cutting-edge field of artificial intelligence medical solutions with two objectives: devices to improve patient comfort and medical imaging AI software to speed up complex reading analysis by radiologists.
Functional And Active Ingredients
Sceti K.K is also the perfect entry point in Japan to distribute and market a variety of Life Science ingredients that provide innovative solutions for Food and Beverage, Cosmetic and Pharmaceutical industries.
Functional And Active Ingredients
Sceti K.K is also the perfect entry point in Japan to distribute and market a variety of Life Science ingredients that provide innovative solutions for Food and Beverage, Cosmetic and Pharmaceutical industries.
Talk To Our Experts
If you are looking for innovative technologies or wish to distribute a cutting-edge solution in Japan and SE Asia, we invite you to contact our experts in these fields:
Nuclear medicine and sterilization devices
Talk To Our Experts
If you are looking for innovative technologies or wish to distribute a cutting-edge solution in Japan and SE Asia, we invite you to contact our experts in these fields:
Nuclear medicine and sterilization devices
AI & Cloud-based medical solutions
Functional and active ingredients
AI & Cloud-based Medical Solutions Enquiry
Talk to us!
Seeking information, willing to share information. Our policy is to acknowledge non-frivolous inquiries or questions within 48 hours.
AI & Cloud-based Medical Solutions Enquiry
Seeking information, willing to share information. Our policy is to acknowledge non-frivolous inquiries or questions within 48 hours.
